NA
TCRR

NewEdge Advisors’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History

NewEdge Advisors’s Portfolio TCRR Stock Details TCRR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-47
Closed -$47 – 4311
2022
Q4 		$47 Buy
+47
New +$47 ﹤0.01% 3484